source
- Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spendingNovartis CEO Vas Narasimhan said the Swiss company is “very disappointed” by Germany’s plan to shave off more than €60 billion in healthcare costs that would affect pharma sales. Germany wants to s…Endpoints · 3mo ago↗ source
- Boehringer, Zealand’s obesity shot looks as good as Novo's Wegovy, but weaker than Lilly's ZepboundObesity patients taking the weight loss injection being developed by Boehringer Ingelheim lost nearly 17% of their weight after about a year and a half, the company said Tuesday. The results are mo…Endpoints · 3mo ago↗ source
- Erasca reports RAS cancer drug data after legal threat from RevolutionAfter a new drug from Revolution Medicines reignited hopes for treating pancreatic cancer, a rival compound from Erasca — which released early-stage data on Monday — could prompt a legal showdown b…